The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...

Vertex Pharmaceuticals (VRTX – Research Report) received a Buy rating and a $480.00 price target from Cantor Fitzgerald analyst Olivia Brayer ...

Summers Value Partners, an investment management company, released its fourth quarter 2024 investor letter. A copy of the ...

These healthcare REITs are rated Buy at Jefferies and make sense now for investors seeking dependable passive income and a ...

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a ...

The final move, made by Larry Culp, was to break GE into three businesses: GE Verona, GE Healthcare , and GE Aerospace. The ...

European shares were at a record high on Friday, led by technology and healthcare stocks, even as caution prevailed ahead of ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

DeepSeek's AI model causes tech stocks to drop, but healthcare tech ETFs benefit from advancements in AI without vulnerability to market volatility.

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...